Detection of p16 gene deletions in gliomas: A comparison of fluorescence in situ hybridization (FISH) versus quantitative PCR

Arie Perry, Tsutomu Nobori, Ning Ru, Kari Anderl, Thomas J. Borell, Gayatry Mohapatra, Burt G. Feuerstein, Robert Brian Jenkins, Dennis A. Carson

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

The p16 protein plays a key role in cell cycle control by preventing CDK4 from inactivating the retinoblastoma protein (pRb). The corresponding tumor suppressor gene (p16/MTS1/CDKN2) has recently been implicated in malignant progression of astrocytomas and could potentially serve as an important marker for patient prognosis and for guiding specific therapeutic strategies. We have undertaken a study to evaluate 2 methods of detecting p16 deletion. Thirty diffuse gliomas were analyzed for p16 gene dosage. Dual color fluorescence in situ hybridization (FISH) was performed on cytologic preparations using paired centromeric (CEN) and locus-specific probes for CEN9/p16, CEN8/RB, and CEN12/CDK4. Quantitative PCR was performed using primers for p16, MTAP, and reference genes. Eleven cases were also studied using comparative genomic hybridization (CGH). Abnormalities of the p16- CDK4-RB pathway were identified in 21 (70%) cases by FISH and/or PCR. These included 15 (50%) with p16 deletion, 9 of which were detected by both techniques, 3 by FISH alone, and 3 by PCR alone (concordance rate = 81%). FISH analysis further revealed tetraploidy/aneuploidy in 14 (47%), RB deletion in 11 (37%), and CDK4 amplification in 1 (3.3%). There were 94% and 100% concordance rates between CGH and FISH or PCR, respectively. Quantitative PCR was noninformative in 4 cases. Although FISH and quantitative PCR are both reliable techniques, each has limitations. PCR is likely to miss p16 deletions when there is significant normal cell contamination or clonal heterogeneity, whereas the p16 YAC probe used for FISH analysis may miss small deletions. Replacement of the latter with a cosmid probe may improve the sensitivity of FISH in future experiments.

Original languageEnglish (US)
Pages (from-to)999-1008
Number of pages10
JournalJournal of Neuropathology and Experimental Neurology
Volume56
Issue number9
StatePublished - Sep 1997

Fingerprint

p16 Genes
Gene Deletion
Fluorescence In Situ Hybridization
Glioma
Polymerase Chain Reaction
Comparative Genomic Hybridization
Retinoblastoma Protein
Cosmids
Tetraploidy
Gene Dosage
Astrocytoma
Aneuploidy
Cell Cycle Checkpoints
Tumor Suppressor Genes
In Situ Hybridization
Color

Keywords

  • Astrocytoma
  • Comparative genomic hybridization
  • Cyclin dependent kinases
  • Fluorescence in situ hybridization
  • p16 gene
  • Polymerase chain reaction
  • Retinoblastoma genes

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Neuroscience(all)

Cite this

Perry, A., Nobori, T., Ru, N., Anderl, K., Borell, T. J., Mohapatra, G., ... Carson, D. A. (1997). Detection of p16 gene deletions in gliomas: A comparison of fluorescence in situ hybridization (FISH) versus quantitative PCR. Journal of Neuropathology and Experimental Neurology, 56(9), 999-1008.

Detection of p16 gene deletions in gliomas : A comparison of fluorescence in situ hybridization (FISH) versus quantitative PCR. / Perry, Arie; Nobori, Tsutomu; Ru, Ning; Anderl, Kari; Borell, Thomas J.; Mohapatra, Gayatry; Feuerstein, Burt G.; Jenkins, Robert Brian; Carson, Dennis A.

In: Journal of Neuropathology and Experimental Neurology, Vol. 56, No. 9, 09.1997, p. 999-1008.

Research output: Contribution to journalArticle

Perry, A, Nobori, T, Ru, N, Anderl, K, Borell, TJ, Mohapatra, G, Feuerstein, BG, Jenkins, RB & Carson, DA 1997, 'Detection of p16 gene deletions in gliomas: A comparison of fluorescence in situ hybridization (FISH) versus quantitative PCR', Journal of Neuropathology and Experimental Neurology, vol. 56, no. 9, pp. 999-1008.
Perry, Arie ; Nobori, Tsutomu ; Ru, Ning ; Anderl, Kari ; Borell, Thomas J. ; Mohapatra, Gayatry ; Feuerstein, Burt G. ; Jenkins, Robert Brian ; Carson, Dennis A. / Detection of p16 gene deletions in gliomas : A comparison of fluorescence in situ hybridization (FISH) versus quantitative PCR. In: Journal of Neuropathology and Experimental Neurology. 1997 ; Vol. 56, No. 9. pp. 999-1008.
@article{9374373289d54cb39688eb793a598c55,
title = "Detection of p16 gene deletions in gliomas: A comparison of fluorescence in situ hybridization (FISH) versus quantitative PCR",
abstract = "The p16 protein plays a key role in cell cycle control by preventing CDK4 from inactivating the retinoblastoma protein (pRb). The corresponding tumor suppressor gene (p16/MTS1/CDKN2) has recently been implicated in malignant progression of astrocytomas and could potentially serve as an important marker for patient prognosis and for guiding specific therapeutic strategies. We have undertaken a study to evaluate 2 methods of detecting p16 deletion. Thirty diffuse gliomas were analyzed for p16 gene dosage. Dual color fluorescence in situ hybridization (FISH) was performed on cytologic preparations using paired centromeric (CEN) and locus-specific probes for CEN9/p16, CEN8/RB, and CEN12/CDK4. Quantitative PCR was performed using primers for p16, MTAP, and reference genes. Eleven cases were also studied using comparative genomic hybridization (CGH). Abnormalities of the p16- CDK4-RB pathway were identified in 21 (70{\%}) cases by FISH and/or PCR. These included 15 (50{\%}) with p16 deletion, 9 of which were detected by both techniques, 3 by FISH alone, and 3 by PCR alone (concordance rate = 81{\%}). FISH analysis further revealed tetraploidy/aneuploidy in 14 (47{\%}), RB deletion in 11 (37{\%}), and CDK4 amplification in 1 (3.3{\%}). There were 94{\%} and 100{\%} concordance rates between CGH and FISH or PCR, respectively. Quantitative PCR was noninformative in 4 cases. Although FISH and quantitative PCR are both reliable techniques, each has limitations. PCR is likely to miss p16 deletions when there is significant normal cell contamination or clonal heterogeneity, whereas the p16 YAC probe used for FISH analysis may miss small deletions. Replacement of the latter with a cosmid probe may improve the sensitivity of FISH in future experiments.",
keywords = "Astrocytoma, Comparative genomic hybridization, Cyclin dependent kinases, Fluorescence in situ hybridization, p16 gene, Polymerase chain reaction, Retinoblastoma genes",
author = "Arie Perry and Tsutomu Nobori and Ning Ru and Kari Anderl and Borell, {Thomas J.} and Gayatry Mohapatra and Feuerstein, {Burt G.} and Jenkins, {Robert Brian} and Carson, {Dennis A.}",
year = "1997",
month = "9",
language = "English (US)",
volume = "56",
pages = "999--1008",
journal = "American Journal of Psychotherapy",
issn = "0002-9564",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Detection of p16 gene deletions in gliomas

T2 - A comparison of fluorescence in situ hybridization (FISH) versus quantitative PCR

AU - Perry, Arie

AU - Nobori, Tsutomu

AU - Ru, Ning

AU - Anderl, Kari

AU - Borell, Thomas J.

AU - Mohapatra, Gayatry

AU - Feuerstein, Burt G.

AU - Jenkins, Robert Brian

AU - Carson, Dennis A.

PY - 1997/9

Y1 - 1997/9

N2 - The p16 protein plays a key role in cell cycle control by preventing CDK4 from inactivating the retinoblastoma protein (pRb). The corresponding tumor suppressor gene (p16/MTS1/CDKN2) has recently been implicated in malignant progression of astrocytomas and could potentially serve as an important marker for patient prognosis and for guiding specific therapeutic strategies. We have undertaken a study to evaluate 2 methods of detecting p16 deletion. Thirty diffuse gliomas were analyzed for p16 gene dosage. Dual color fluorescence in situ hybridization (FISH) was performed on cytologic preparations using paired centromeric (CEN) and locus-specific probes for CEN9/p16, CEN8/RB, and CEN12/CDK4. Quantitative PCR was performed using primers for p16, MTAP, and reference genes. Eleven cases were also studied using comparative genomic hybridization (CGH). Abnormalities of the p16- CDK4-RB pathway were identified in 21 (70%) cases by FISH and/or PCR. These included 15 (50%) with p16 deletion, 9 of which were detected by both techniques, 3 by FISH alone, and 3 by PCR alone (concordance rate = 81%). FISH analysis further revealed tetraploidy/aneuploidy in 14 (47%), RB deletion in 11 (37%), and CDK4 amplification in 1 (3.3%). There were 94% and 100% concordance rates between CGH and FISH or PCR, respectively. Quantitative PCR was noninformative in 4 cases. Although FISH and quantitative PCR are both reliable techniques, each has limitations. PCR is likely to miss p16 deletions when there is significant normal cell contamination or clonal heterogeneity, whereas the p16 YAC probe used for FISH analysis may miss small deletions. Replacement of the latter with a cosmid probe may improve the sensitivity of FISH in future experiments.

AB - The p16 protein plays a key role in cell cycle control by preventing CDK4 from inactivating the retinoblastoma protein (pRb). The corresponding tumor suppressor gene (p16/MTS1/CDKN2) has recently been implicated in malignant progression of astrocytomas and could potentially serve as an important marker for patient prognosis and for guiding specific therapeutic strategies. We have undertaken a study to evaluate 2 methods of detecting p16 deletion. Thirty diffuse gliomas were analyzed for p16 gene dosage. Dual color fluorescence in situ hybridization (FISH) was performed on cytologic preparations using paired centromeric (CEN) and locus-specific probes for CEN9/p16, CEN8/RB, and CEN12/CDK4. Quantitative PCR was performed using primers for p16, MTAP, and reference genes. Eleven cases were also studied using comparative genomic hybridization (CGH). Abnormalities of the p16- CDK4-RB pathway were identified in 21 (70%) cases by FISH and/or PCR. These included 15 (50%) with p16 deletion, 9 of which were detected by both techniques, 3 by FISH alone, and 3 by PCR alone (concordance rate = 81%). FISH analysis further revealed tetraploidy/aneuploidy in 14 (47%), RB deletion in 11 (37%), and CDK4 amplification in 1 (3.3%). There were 94% and 100% concordance rates between CGH and FISH or PCR, respectively. Quantitative PCR was noninformative in 4 cases. Although FISH and quantitative PCR are both reliable techniques, each has limitations. PCR is likely to miss p16 deletions when there is significant normal cell contamination or clonal heterogeneity, whereas the p16 YAC probe used for FISH analysis may miss small deletions. Replacement of the latter with a cosmid probe may improve the sensitivity of FISH in future experiments.

KW - Astrocytoma

KW - Comparative genomic hybridization

KW - Cyclin dependent kinases

KW - Fluorescence in situ hybridization

KW - p16 gene

KW - Polymerase chain reaction

KW - Retinoblastoma genes

UR - http://www.scopus.com/inward/record.url?scp=0030929534&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030929534&partnerID=8YFLogxK

M3 - Article

C2 - 9291941

AN - SCOPUS:0030929534

VL - 56

SP - 999

EP - 1008

JO - American Journal of Psychotherapy

JF - American Journal of Psychotherapy

SN - 0002-9564

IS - 9

ER -